Skip to content
10-K

Annual Report

HARTE HANKS, INC. HHS

0000045919-25-000008

← back to feed
Filed
Mar 17, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 28, 2025 7.36M sh
Stock Repurchased FY 2024 · Dec 31, 2024 $0
Stock Repurchased FY 2024 · Dec 31, 2023 $2.37M
Shares Diluted FY 2024 · Dec 31, 2023 7.31M sh
Capex FY 2024 · Dec 31, 2023 $2.81M
Operating Cash Flow FY 2024 · Dec 31, 2023 $10.48M
Cash And Equivalents FY 2024 · Dec 31, 2023 $18.36M
Current Liabilities FY 2024 · Dec 31, 2023 $48.11M
Total Liabilities FY 2024 · Dec 31, 2023 $102.9M
Current Assets FY 2024 · Dec 31, 2023 $65.21M
Total Assets FY 2024 · Dec 31, 2023 $122.76M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.21
Eps Basic FY 2024 · Dec 31, 2023 −$0.21
Sga Expense FY 2024 · Dec 31, 2023 $20.67M
Net Income FY 2024 · Dec 31, 2023 −$1.57M
Operating Income FY 2024 · Dec 31, 2023 $3.36M
Revenue FY 2024 · Dec 31, 2023 $191.49M
Stockholders Equity FY 2024 · Dec 31, 2022 $18.81M